Mechanism of amyloid-β (Aβ) removal via Aβ-specific antibodies. FcR =... | Download Scientific Diagram
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches - The Lancet Neurology
Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease | Nature Communications
Frontiers | Ophthalmic Biomarkers for Alzheimer's Disease: A Review
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
New Alzheimer's Biomarkers may Support Early Diagnosis
Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity | Biochemistry
Amyloid MS | Research & Development | SHIMADZU CORPORATION
Amphiphilic Distyrylbenzene Derivatives as Potential Therapeutic and Imaging Agents for Soluble and Insoluble Amyloid β Aggregates in Alzheimer's Disease | Journal of the American Chemical Society
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease | PLOS ONE
The complexity of Alzheimer's disease: an evolving puzzle | Physiological Reviews
Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease: Neuron
Cells | Free Full-Text | Circular RNA Encoded Amyloid Beta peptides—A Novel Putative Player in Alzheimer's Disease
β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification | Alzheimer's Research & Therapy | Full Text
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline? | PLOS Biology
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study - The Lancet Neurology
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models: Cell
Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques | Scientific Reports
Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease - ScienceDirect
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease | Nature Medicine
